en-bloc® Breast Biopsy System

Recently, the FDA approved expanded indications for a breast biopsy system — the en-bloc, made by Neothermia Corp.. Now surgeons operating the en-bloc can obtain tissue samples for histologic examination with partial or complete removal of an imaged abnormality, or partial removal of a palpable abnormality that has been classified as benign (eg, fibroadenoma, fibrocystic lesion).
The approval was based on study data showing that the device was equivalent to core biopsy for removing imaged lesions of the breast and providing complete captures of every imaged target with fewer attempts.
The system consists of an image-guided, vacuum-assisted probe that is inserted through a small incision in the breast – unlike excisional surgical biopsy, the minimally invasive procedure can be performed in an outpatient setting.
Find out more at Neothermia Corporation web site…